EMA
guidance
· 2016-02-02
How to facilitate development of cancer immunotherapies
Summary
EMA guidance outlining considerations to facilitate the development of cancer immunotherapies, including design, translational science, and regulatory expectati…
Upgrade for the full analysis, importance score, and drug timeline.